US Patent 11306297 Therapeutic nuclease compositions and methods
Patent 11306297 was granted and assigned to University of Washington on April, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Jeffrey A. Ledbetter0
Keith Elkon0
Martha Hayden-Ledbetter0
Xizhang Sun0
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113062970
Date of Patent
April 19, 2022
0Patent Application Number
156797460
Date Filed
August 17, 2017
0Patent Citations
Patent Primary Examiner
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 5 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 18 May, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+186 characters)
US Patent 11306297 Therapeutic nuclease compositions and methods
Article
Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11306297
Date of patent
April 19, 2022
Patent application number
15679746
Date Filed
August 17, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11306297 Therapeutic nuclease compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.